Medidata, a Dassault Systemes (DASTY) brand, and Sanofi (SNY) announced an expansion of their partnership to bolster clinical research. This new agreement will take advantage of the Medidata patient, data, and study experiences. Sanofi will employ Medidata’s expertise and capabilities in decentralized clinical trials as part of this new enterprise agreement. Medidata will also provide strategic consulting and end-to-end operational support, empowering Sanofi to further streamline research processes.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- Trump Trade: Trump administration prepares new probe into pharma prices
- Trump admin prepares new probe into U.S. pharma prices, FT says
- SNY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Sanofi announces Tzield sBLA accepted for expedited review by FDA
- Sanofi says CHMP issues negative opinion on MAA for Rezurock